Leukocyte migration inhibition in vitro in bladder carcinoma.
The leukocyte migration inhibition response in vitro of peripheral blood leukocytes from patients with transitional cell carcinoma of the urinary bladder, other genitourinary diseases, and normal controls was studied. The agarose droplet migration inhibition method was used to determine the cell-mediated immune reactivity of bladder tumor patients to antigens derived from allogeneic bladder tumor cell lines by hypertonic potassium chloride extraction. Sixty-nine bladder tumor patients were tested 131 times and included 68 positive and 63 negative results. A positive assay was shown to correlate strongly with the presence of tumor at the time of testing (p less than 0.001). Five of 24 patients with other genitourinary diseases had positive inhibition assays, but none of the 26 normal controls were positive.  These results suggest that this in vitro assay method may prove valuable in monitoring bladder tumor patients for completeness of initial tumor resection and for clinical recurrence as well as for further studies of the tumor-specific immune response in this disease.
D000951:Antigens, Neoplasm / Q000008:administration & dosage; D002295:Carcinoma, Transitional Cell / Q000175:diagnosis / Q000276:immunology* / Q000601:surgery; D002464:Cell Migration Inhibition; D003951:Diagnostic Errors; D006801:Humans; D007111:Immunity, Cellular; D066298:In Vitro Techniques; D007962:Leukocytes / Q000276:immunology*; D013997:Time Factors; D001749:Urinary Bladder Neoplasms / Q000175:diagnosis / Q000276:immunology* / Q000601:surgery
D000951:Antigens, Neoplasm